APA

Sobocinski J., Maurel B., Delsart P., d'Elia P., Guillou M., Maioli F., Perot C., Bianchini A., Azzaoui R., Mounier-Vehier C. & Haulon S. (20111031). Should we modify our indications after the EVAR-2 trial conclusions?. : Annals of vascular surgery.

Chicago

Sobocinski Jonathan, Maurel Blandine, Delsart Pascal, d'Elia Piervito, Guillou Matthieu, Maioli Filippo, Perot Céline, Bianchini Aurélia, Azzaoui Richard, Mounier-Vehier Claire and Haulon Stéphan. 20111031. Should we modify our indications after the EVAR-2 trial conclusions?. : Annals of vascular surgery.

Harvard

Sobocinski J., Maurel B., Delsart P., d'Elia P., Guillou M., Maioli F., Perot C., Bianchini A., Azzaoui R., Mounier-Vehier C. and Haulon S. (20111031). Should we modify our indications after the EVAR-2 trial conclusions?. : Annals of vascular surgery.

MLA

Sobocinski Jonathan, Maurel Blandine, Delsart Pascal, d'Elia Piervito, Guillou Matthieu, Maioli Filippo, Perot Céline, Bianchini Aurélia, Azzaoui Richard, Mounier-Vehier Claire and Haulon Stéphan. Should we modify our indications after the EVAR-2 trial conclusions?. : Annals of vascular surgery. 20111031.